Form 4 for NOC Northrop Grumman
Accepted 2024-02-16 00:00:00 ET · period of report 2024-02-14 · accession 0001628280-24-005305 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-16 | 2024-02-14 | NOC | Warden Kathy J | COB, CEO, Pres, Dir | F - Tax | $446.37 | -20.3K | 186.7K | -10% | -$9.08M |
| D | 2024-02-16 | 2024-02-14 | NOC | Warden Kathy J | COB, CEO, Pres, Dir | M - OptEx | $0.00 | +45.8K | 207.1K | +28% | $0 |
| DM | 2024-02-16 | 2024-02-14 | NOC | Warden Kathy J | COB, CEO, Pres, Dir | A - Grant | $0.00 | +48.8K | 119.0K | +69% | $0 |
| D | 2024-02-16 | 2024-02-14 | NOC | Warden Kathy J | COB, CEO, Pres, Dir | M - OptEx | $0.00 | -45.8K | 73.2K | -39% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-14 | F | D | 20,335 | $446.37 | 186,728.13 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-14 | M | A | 45,832.05 | $0.00 | 207,063.13 | D | — | — | |
| 3 | Derivative | Restricted Stock Rights | 2024-02-14 | A | A | 11,155 | $0.00 | 48,363 | D | — · — to — | 11,155 Common Stock | (F1) Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the Long-Term Incentive Stock Plan ("LTISP") on 2/14/24 and will vest on 2/14/27. |
| 4 | Derivative | Restricted Performance Stock Rights | 2024-02-14 | A | A | 37,636.05 | $0.00 | 119,044.05 | D | — · — to — | 37,636.05 Common Stock | (F3) The RPSRs acquired include (i) 13,327.05 vested RPSRs with respect to the measurement period ended 12/31/23 acquired due to settlement of the RPSRs granted under the LTISP on 2/16/21 that resulted in settlement at 141% of the target award; and (ii) 24,309 unvested RPSRs granted under the LTISP on 2/14/24 with a measurement period ending on 12/31/26. A total of 45,832.05 shares were issued in settlement of the 2021 RPSRs with a measurement period that ended 12/31/23, and the target award amount of 32,505 RPSRs was previously reported in connection with the grant of the 2021 RPSRs. (F2) Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). |
| 5 | Derivative | Restricted Performance Stock Rights | 2024-02-14 | M | D | 45,832.05 | $0.00 | 73,212 | D | — · — to — | 45,832.05 Common Stock | (F2) Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). |